Cytek Biosciences, Inc. (NasdaqGS:CTKB) is looking for M&A. Patrik Jeanmonod, Chief Financial Officer said, "We will continue to invest in our core business as it relates to new project and innovation while remaining opportunistic in the M&A environment and focusing on growth in all key areas".